SpyGlass Cholangioscopy with Laser Lithotripsy
Cutting-edge, single-operator endoscopic management of difficult biliary stones under direct visualization.
Overview and Key Advantage
SpyGlass Cholangioscopy integrates a slim, steerable fiber-optic endoscope with the ERCP platform, empowering a single endoscopist to directly visualize the biliary tree and perform targeted interventions—most notably laser lithotripsy of large or impacted stones—within one session. This approach achieves high stone-clearance rates while minimizing invasiveness, hospital stay, and complication rates compared with conventional methods.
Indications
-
Difficult bile duct stones (large >1.5–2 cm, impacted, or failed conventional extraction)
-
Mirizzi syndrome with cystic duct or Hartmann’s pouch stones
-
Indeterminate strictures (targeted biopsy under direct vision)
-
Recurrent or intrahepatic duct stones resistant to standard ERCP techniques
-
Pancreatic duct stones when combined with peroral pancreatoscopy
Procedural Steps
-
Preparation & Access
Perform ERCP with sphincterotomy; introduce a guidewire into the bile duct. -
SpyGlass Catheter Insertion
Attach SpyScope catheter to the duodenoscope; advance over guidewire into bile duct under fluoroscopy. -
Direct Visualization
Deploy the optical probe via the catheter; irrigation enhances visibility. -
Laser Lithotripsy
– Use a Ho:YAG laser fiber (typically 270 µm) positioned ~2 mm from stone.
– Start at 1 Joule/10 Hz (10 W); adjust energy (up to 2.4 Joule) and frequency for refractory stones.
– Fragmentation is observed under direct vision. -
Stone Extraction
Remove fragments with balloon or basket; confirm clearance endoscopically. -
Stenting (if needed)
Place biliary (or pancreatic) stent for duct decompression or prophylaxis.
Clinical Outcomes
| Metric | Result |
|---|---|
| Overall stone-clearance rate | 95.6%–97.3% |
| Single-session clearance | 63%–83% |
| Median procedure time | 49–90 minutes |
| Adverse event rate | 2.9%–12% (cholangitis, pancreatitis) |
| Diagnostic sensitivity for malignancy by visual impression | 90%–96.6% |
| Diagnostic specificity for malignancy by biopsy | 93.3%–100% |
Benefits
-
High efficacy in fragmenting and clearing complex stones in a single session.
-
Direct targeted therapy reduces need for mechanical lithotripsy or multiple ERCPs.
-
Accurate diagnosis and biopsy under direct vision improves evaluation of strictures.
-
Shorter hospital stay and faster recovery than laparoscopic exploration.
-
Single-operator workflow simplifies logistics and resource utilization
Risks and Limitations
-
Cholangitis or pancreatitis in 3%–12% of cases, typically managed conservatively.
-
Laser-induced mucosal injury if probe is too close (<1 mm) to duct wall
-
Steep learning curve for image interpretation and probe manipulation
-
Scope fragility requires careful handling
Patient Selection and Preparation
-
Evaluate stone size, number, and ductal anatomy via MRCP or cholangiogram
-
Ensure patients have no contraindications to ERCP or sedation
-
Prophylactic antibiotics may be administered in high-risk cases
Post-Procedure Care
-
Monitor for signs of cholangitis, pancreatitis, or perforation
-
Remove biliary stent in 4–6 weeks if placed
-
Schedule follow-up imaging to confirm sustained clearance
SpyGlass Cholangioscopy with Laser Lithotripsy represents a paradigm shift in management of challenging biliary stones, combining high technical success with a favorable safety profile and the convenience of a single-operator platform.


